Author

Dengqiang Lin

Observed names: D. Lin, D.T. Lin

Institutions: Fudan University, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University

Observed institutions: Fudan University, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Shanghai First People's Hospital, Kaiser Permanente Northern California

ORCID: 0000-0002-6732-6043

Observed ORCID: 0000-0002-6732-6043

OpenAlex ID: A5036078419

Radiomics predict the WHO/ISUP nuclear grade and survival in clear cell renal cell carcinoma

2024 · Xiaoxia Li, Jinglai Lin, et al. · Insights into Imaging · 29

Differentiating Fat-Poor Angiomyolipoma from Renal Cell Carcinoma Using Contrast-Enhanced CT

2026 · Jinglai Lin, Letong Zhang, et al. · Bioengineering

Differentiating Fat-Poor Angiomyolipoma From Renal Cell Carcinoma Using Contrast-Enhanced CT: Development and External Validation of an AI-Assisted Diagnostic Model

2026 · Jinglai Lin, Letong Zhang, et al. · Research Square

Mendelian Randomization and Single-Cell Analyses Identify the Links Between IL6 and Pan B Cells in Clear Cell Renal Cell Carcinoma

2025 · Dengqiang Lin, Jinglai Lin, et al. · Research Square

P3.06D.02 Dynamic ctDNA-mrd Indicates Pathological Benefits of Additional Neoadjuvant Chemoimmunotherapy Courses for Locally Advanced NSCLC

2024 · D. Lin, X. Wang, et al. · Journal of Thoracic Oncology

Can Gender-Specific Renal and Visceral Fat Evaluated by CT Predict the Fuhrman Nuclear Classification of Clear Cell Renal Cell Carcinoma?

2024 · Xiaoxia Li, Jinglai Lin, et al. · Current Medical Imaging Formerly Current Medical Imaging Reviews

Works count: 9

Citation count: 29

H-index: 1

I10-index: 1